创业慧康(300451.SZ)：clawdbot 对公司现有业务无直接影响

Core Viewpoint - The company emphasizes that the clawdbot has no direct impact on its existing business and is committed to advancing its "Huikang Cloud Strategic Planning" to enhance product innovation and system reliability [1] Group 1: Business Strategy - The company will focus on continuous product innovation and the deepening of core system applications, particularly HI-HIS, to improve system reliability and data security [1] - The company aims to optimize implementation processes and build a standardized delivery system to ensure efficient project execution [1] - Collaboration with ecosystem partners will be prioritized to integrate medical scene demands with cutting-edge technology, accelerating the transformation of R&D results [1] Group 2: Competitive Advantage - The company plans to strengthen its product technology barriers and core competitive advantages through enhanced development support and operational knowledge accumulation [1] - A standardized toolchain will be established to improve the professional capabilities of the delivery team, alongside a rapid deployment mechanism to address short-term market challenges [1] Group 3: Market Outlook - The company expresses confidence in the broad prospects of the medical information industry and the ongoing core demands of clients [1] - With enhanced product technology strength, improved project delivery efficiency, and innovative applications in the medical AI field, the company will continue to deepen its focus on the medical information sector [1] - The company aims to explore new models and paths for smart hospital construction in collaboration with various medical institutions, contributing to high-quality development in healthcare [1]